Research & Development

大香蕉伊人久草av伊人在线大香蕉网4久草大香蕉网伊人在线桑德斯才宣布參選1天 募得600萬 傲視民主黨參選人


  聶壹瞅著又緩緩逼近的匈奴人,揮揮手里的旗子,簇擁著霍去病迅速離開了旱獺地。   此時此刻,如果將劉陵的事跡傳回大漢國,相信人們不再說她齷齪不堪的往事。大香蕉伊人久草av   “我還是不喜歡!”伊人在线大香蕉网4久草   就懶懶的揮揮手道︰“別擋著我曬太陽!”   謝寧道︰“大閼氏也沒有忘記,否則,也不會把小王子交給我們兄弟了,跟著我們兄弟長大的孩子,你說,他是匈奴人呢,還是大漢人?”大香蕉网伊人在线   完成了田氏代齊的偉大使命。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo